467 related articles for article (PubMed ID: 32792454)
1. TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
Birkhäuser V; Liechti MD; Anderson CE; Bachmann LM; Baumann S; Baumberger M; Birder LA; Botter SM; Büeler S; Cruz CD; David G; Freund P; Friedl S; Gross O; Hund-Georgiadis M; Husmann K; Jordan X; Koschorke M; Leitner L; Luca E; Mehnert U; Möhr S; Mohammadzada F; Monastyrskaya K; Pfender N; Pohl D; Sadri H; Sartori AM; Schubert M; Sprengel K; Stalder SA; Stoyanov J; Stress C; Tatu A; Tawadros C; van der Lely S; Wöllner J; Zubler V; Curt A; Pannek J; Brinkhof MWG; Kessler TM
BMJ Open; 2020 Aug; 10(8):e039164. PubMed ID: 32792454
[TBL] [Abstract][Full Text] [Related]
2. Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial.
Li J; Wang J; Hu Y; Jian R; Zhao Y; Li D; Wan T; Jike W; Xu F; Huang M
Trials; 2023 Mar; 24(1):199. PubMed ID: 36932375
[TBL] [Abstract][Full Text] [Related]
3. Effects of Bilateral Transcutaneous Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Spinal Cord Injury: A Urodynamic Study.
Kamboonlert K; Panyasriwanit S; Tantisiriwat N; Kitisomprayoonkul W
Arch Phys Med Rehabil; 2021 Jun; 102(6):1165-1169. PubMed ID: 33245938
[TBL] [Abstract][Full Text] [Related]
4. Update from TASCI, a Nationwide, Randomized, Sham-controlled, Double-blind Clinical Trial on Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity.
Liechti MD; van der Lely S; Stalder SA; Anderson CE; Birkhäuser V; Bachmann LM; Brinkhof MWG; Curt A; Jordan X; Leitner L; Mehnert U; Möhr S; Pannek J; Schubert M; Kessler TM;
Eur Urol Focus; 2020 Sep; 6(5):877-879. PubMed ID: 31601539
[TBL] [Abstract][Full Text] [Related]
5. bTUNED: transcutaneous tibial nerve stimulation for neurogenic lower urinary tract dysfunction.
Stalder SA; Gross O; Anderson CE; Bachmann LM; Baumann S; Birkhäuser V; Bywater M; Del Popolo G; Engeler DS; Agrò EF; Friedl S; Grilo N; Kiss S; Koschorke M; Leitner L; Liechti MD; Mehnert U; Musco S; Sadri H; Stächele L; Tornic J; van der Lely S; Wyler S; Kessler TM
BJU Int; 2023 Sep; 132(3):343-352. PubMed ID: 37204144
[TBL] [Abstract][Full Text] [Related]
6. Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder: A Randomized Control Pilot Trial.
Stampas A; Korupolu R; Zhu L; Smith CP; Gustafson K
Neuromodulation; 2019 Aug; 22(6):716-722. PubMed ID: 30284350
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Pilot Study for an International Multicenter Randomized Controlled Trial.
Tornic J; Liechti MD; Stalder SA; Birkhäuser V; van der Lely S; Leitner L; Mehnert U; Kessler TM
Eur Urol Focus; 2020 Sep; 6(5):909-915. PubMed ID: 31810854
[TBL] [Abstract][Full Text] [Related]
8. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
Walter M; Ramirez AL; Lee AH; Rapoport D; Kavanagh A; Krassioukov AV
BMJ Open; 2018 Nov; 8(11):e024084. PubMed ID: 30467135
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
[TBL] [Abstract][Full Text] [Related]
11. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study.
Bourbeau DJ; Gustafson KJ; Brose SW
J Spinal Cord Med; 2019 May; 42(3):360-370. PubMed ID: 29334338
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of sacral root magnetic stimulation with transcutaneous posterior tibial nerve stimulation in the treatment of neurogenic detrusor overactivity: an exploratory randomized controlled trial.
Zhao Y; Wang D; Zou L; Mao L; Yu Y; Zhang T; Bai B; Chen Z
Transl Androl Urol; 2022 Jun; 11(6):821-831. PubMed ID: 35812198
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-STARTUP.
McClurg D; Panicker J; Walker RW; Cunnington A; Deane KHO; Harari D; Elders A; Booth J; Hagen S; Mason H; Stratton S
BMJ Open; 2020 Feb; 10(2):e034887. PubMed ID: 32071190
[TBL] [Abstract][Full Text] [Related]
14. Bladder Neuromodulation in Acute Spinal Cord Injury via Transcutaneous Tibial Nerve Stimulation: Cystometrogram and Autonomic Nervous System Evidence From a Randomized Control Pilot Trial.
Stampas A; Gustafson K; Korupolu R; Smith C; Zhu L; Li S
Front Neurosci; 2019; 13():119. PubMed ID: 30837835
[No Abstract] [Full Text] [Related]
15. Initial experience with the treatment of neurogenic detrusor overactivity with a new β-3 agonist (mirabegron) in patients with spinal cord injury.
Wöllner J; Pannek J
Spinal Cord; 2016 Jan; 54(1):78-82. PubMed ID: 26503222
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
18. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Denys P; Castaño Botero JC; Vita Nunes RL; Wachs B; Mendes Gomes C; Krivoborodov G; Tu LM; Del-Popolo G; Thompson C; Vilain C; Volteau M; Kennelly M;
Neurourol Urodyn; 2023 Jan; 42(1):153-167. PubMed ID: 36321799
[TBL] [Abstract][Full Text] [Related]
19. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
Martin-Garcia M; Crampton J
Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
